GlaxoSmithKline to acquire oral care company Biotene
NEW YORK GlaxoSmithKline is buying rights to the dry-mouth drug Biotene from California drug maker Laclede, GSK has announced.
“The acquisition of Biotene extends our portfolio in therapeutic oral health care to include a proven treatment for dry mouth,” GSK Consumer Healthcare president John Clarke said in a statement. “This opportunity leverages our global capability with dental and medical professionals and is a further step towards our goal in GSK of building and growing a diversified healthcare business.”
Biotene generated $50 million in sales for Laclede last year, according to GSK.
Sephora purchases stake in Russian beauty chain Ile de Beaute
PARIS Sephora SA, a division of LVMH Moet Hennessy Louis Vuitton, has acquired a 45 percent stake in the Russian perfumery chain Ile de Beaute—a move that will enable Sephora to become a major player in the market over the next few years.
The agreement gives Sephora SA the option to become a majority shareholder in Ile de Beaute over time. The current management team will remain in place.
Ile de Beaute is one of the leading distributors of perfume and cosmetics in Russia. The move is aligned with Sephora’s international strategy to expand into markets with strong potential. According to the company, Russia is a high growth market for perfumes and cosmetics and has become one of the leading markets in Europe in this area.
Ile de Beaute will have a total of approximately 100 stores at the end of 2008, making it one of the leading companies in the Russian market.
The existing franchise between Sephora and Alkor, through which the latter operates the Sephora stores in Russia, will remain in place until its termination, which is provided for in the contract at the end of 2010.
Blistex launches Deep Renewal anti-aging treatment for lips
OAK BROOK, Ill. Blistex on Tuesday announced the introduction of Deep Renewal, a clinically-proven anti-aging product that reduces deep and fine lines on lips. The product is currently available nationwide with a suggested retail price of $2.79.
Blistex Deep Renewal contains some of the advanced ingredients and protectants found in many specialty and high-end anti-aging products, the company stated, at a less expensive pricepoint.
In the course of a full, independent, clinical trial, clinicians and test participants confirmed Blistex Deep Renewal delivered significant visual improvement in lip features such as luster, suppleness and radiance within two hours after an initial application. Over the course of four weeks, visual reports and lip molds confirmed a reduction in the number and depth of lines and wrinkles.
“Blistex Deep Renewal actually erases some of the tell-tale signs of aging without requiring an invasive procedure,” Charles Zugerman, associate professor of dermatology at Northwestern University Medical School, said. “With regular application of Blistex Deep Renewal, lips have a more youthful appearance.”
Blistex Deep Renewal’s list of ingredients include:
• Hyaluronic spheres—a relatively new technology that helps improve skin condition and gives lips a fuller appearance;
• Coenzyme Q-10, a moisturizer; and
• Light refractors, which contribute to improving lips’ luster and youthfulness by defusing light.